Comparing Smoking Cessation Methods Alongside Low-Dose CT Lung Cancer Screening
Tests smoking quit methods with low-dose CT lung screening in adults aged 50 to 74.
Plain-language title generated from the registry record
Registry title: Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer
Key facts
- Where
- Helsinki, Oulu, Tampere, Turku, and Vaasa, FinlandSee the 5 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 50 and 74 years old?
Source: NCT07331519, who can take part
Where in Finland
- Helsinki University HospitalHelsinki, FinlandNot yet recruiting
- Oulu University HospitalOulu, FinlandTaking people
- Tampere University HospitalTampere, FinlandNot yet recruiting
- Turku University HospitalTurku, FinlandNot yet recruiting
- Vaasa Central HospitalVaasa, FinlandNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Oulu University Hospital
- Trial code
- NCT07331519
- Record updated
- 6 February 2026
- Original description
The study investigates effectiveness of different smoking cessation methods and low-dose CT based lung cancer screeningRead full original descriptionShow less
Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer - a Randomized Study
The study investigates effectiveness of different smoking cessation methods and low-dose CT based lung cancer screening
Inclusion: Able to provide written informed consent; Age between 50-74; Smoked ≥ 15 cigarettes/day for ≥ 25 years or smoked ≥ 10 cigarettes/day for ≥ 30 years and are active smokers (smoking during the last two weeks); Access to a smartphone (iPhone or Android).
Exclusion: Current or past melanoma, lung, renal or breast cancer; Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial; Any condition that study investigators consider an impediment to safe trial participation; A chest CT examination less than one year before inclusion; No access to a smartphone (iPhone or Android); Participant is unwilling or unable to comply with treatment and trial instructions.